Wed, Jun 19, 2013, 6:55 AM EDT - U.S. Markets open in 2 hrs 35 mins
This isn't just a stock to be shorted. It is a company that has a future with promising drug candidates, fairly deep pipeline, and an intellectual staff capable of great accomplishments. This is why the high target.
I concur, not only with buying, but the management team, staff and the direction of this company is exceptional. It gives me confidence in my investment.
Short interest as of 5-15-13 by Ameritrade is 28.07%. This is probably higher now and was probably forced down on any news.